Detail

Forgot your Password? Create Account Membership Application Renew Membership

Diabetes: Advancing Our Med-Tech Edge

Presented by LifeScience Alley

10/29/2007

Time

Program: 8:00 am - 6:00 pm
Registration: 7:00 am - 8:00 am

Event Description

An Office of Clinical Research ? LifeScience Alley Breakthrough Series Event

The topic of this Breakthrough Series event is Diabetes, presenting important academic and industry research into treatment using insulin delivery systems, continuous glucose monitoring, islet transplantation, stem cells, and other emerging modalities. Fifteen leading researchers and speakers from the University of Minnesota and industry are confirmed for this full-day program.

Breakthrough technology calls for Breakthrough collaboration between the University of Minnesota and the member organizations of LifeScience Alley. LifeScience Alley has joined with the Office of Clinical Research at the University of Minnesota to launch this educational partnership. This program ? and all in the series ? will be highly interactive. Presentations and panel discussions will add intellectual depth to our understanding of current and future research directions, and will look at emerging interventions from many perspectives. Question-and-answer periods will give everyone opportunities to interact with presenters and with each other. There will be extensive networking opportunities among academic researchers, industry representatives, physicians, insurers, regulatory and clinical professionals, and investors. The purpose here is to enhance Minnesota-based leadership in new technology.

MONDAY ? October 29, 2007

Diabetes meets the new technology:

7:00 Registration and breakfast/coffee

8:00-8:15 Welcome and Opening remarks: Jasit Ahluwalia, MD, MPH, MS and Russell Luepker, MD, MS; Elizabeth Seaquist, MD and Larry Kuusisto, PhD

8:15-8:45 Diabetes: What is the scope of the problem?
Elizabeth Seaquist, MD
Prevalence/incidence; demographics; societal impact; the clinical picture

8:45-9:15 Targeting Glucose Metabolism to Improve Treatment of Type 2 Diabetes
Alex Lange, PhD

9:15-9:30 BREAK

9:30-11:15 Continuous Glucose Monitoring
9:30-10:00 Novel methods to measure interstitial glucose: Ronald Siegel, ScD
10:00-10:30 Medtronic Diabetes: Claudia Graham, PhD
10:30-11:00 International Diabetes Center: Roger Mazze, PhD
11:00-11:30 Panel discussion Q & A

11:30-Noon University of Minnesota ? New Technologies and Business Advancement
Institute for Engineering in Medicine: Arthur Erdman, PhD
Medical Industry Leadership Institute: Stephen Parente, PhD

Noon-1:00 LUNCH

1:00-2:30 Islet Cell Transplantation - Xenotransplantation
1:00-1:30 Using pig islets in primates: Bernhard Hering, MD
1:30-2:00 Where do the pigs come from? Henk-Jan Schuurman, PhD
2:00-2:30 Ethics of xenotransplantation: Jeffrey Kahn, PhD, MPH

2:30-2:45 BREAK

2:45-4:14 Novel Approaches to Diabetes Treatment & Prevention:
2:45-3:15 Use of embryonic stem cells: Meri Firpo, PhD
3:15-3:45 Use of pancreatic stem cells: Jonathan Slack, PhD
3:45-4:15 Is Type 2 Diabetes a Binge-Eating Disorder? Scott Crow, MD

4:15-5:15 The Next Steps ? Advancing our Med-Tech Edge
Panel ? problem solving discussions
Audience Q&A

5:15-6:00 Networking Reception

Speakers:

Jasjit S. Ahluwalia, MD, MPH, MS, Director, AHC Office of Clinical Research; Russell Luepker, MD, MS, Mayo Professor, Division of Epidemiology, School of Public Health; Elizabeth Seaquist, MD, Professor, Division of Endocrinology and Diabetes, Department of Medicine; Director, General Clinical Research Center; Director, Center for Diabetes Research; Pennock Family Chair in Diabetes Research; Larry Kuusisto, PhD, VP Education, LifeScience Alley and Executive Director, Alley Institute; Alex Lange, PhD, Associate Professor, Biochemistry, Molecular Biology and Biophysics; Director, Division of Regulatory Biochemistry; Associate Professor, Medical School; Ronald Seigel, Sc.D., Professor and Department Head, Department of Pharmaceutics, School of Pharmacy; Roger Mazze, PhD, Clinical Professor of Family Practice and Community Medicine; Director of the World Health Organization Collaborating Center for Education, Translation and Computer Technology in Diabetes; Chief Academic Officer of the International Diabetes Center; Bernhard Hering, MD, Professor of Surgery at the University of Minnesota; Scientific Director of the Diabetes Institute for Immunology and Transplantation; Director of the Islet Transplant Program; holder of the Eunice L. Dwan Diabetes Research Chair; Henk-Jan Schuurman, PhD, Executive Director & CEO of Spring Point Project; Jeffrey Kahn, PhD, MPH, Director and Professor, Maas Family Endowed Chair in Bioethics, Center for Bioethics; Professor, Department of Medicine; Meri Firpo, PhD, Associate Professor in the Stem Cell Institute and the Division of Endocrinology , Department of Medicine; Jonathan Slack, PhD, Director, Stem Cell Institute; Professor, Genetics, Cell Biology and Development; Scott Crow, MD, Professor of Psychiatry

University of Minnesota Faculty/Staff/Students - Register here

Office of Clinical Research ? LifeScience Alley Breakthrough Series. The purpose of this continuing series is to spotlight University of Minnesota research and to effectively connect the University with the medical technology industry and healthcare. LifeScience Alley with its more than 500 industry-wide member organizations is unmatched anywhere in the country. We have a unique opportunity here to link world-class research with world-class medical technology, and we intend to build, strengthen, and sustain strong effective relationships.

This Breakthrough series will highlight breakthroughs in health and breakthroughs in collaboration. The University?s Office of Clinical Research and LifeScience Alley intend to create an unparalleled model of academic-industry cooperation